The National Institutes of Health supported a new study that is looking at broader protections from future influenza vaccines—vaccines that could bettter protect from the more virulent H1N1 and H3N2 strains.
Influenza vaccines that target neuraminidase (NA), a surface protein, could provide broad protection against a variety of influenza strains and reduce the severity of illness, according to new research.
Currently, seasonal influenza vaccines primarily target the more abundant surface